World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
24623
World Ranking
17067
National Ranking
686

Giorgina Specchia publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Giorgina Specchia sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 681 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Giorgina Specchia D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Giorgina Specchia sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Giorgina Specchia is affiliated with the University of Bari Aldo Moro in Italy and has an extensive research portfolio in medicine, with a particular focus on hematology. They have contributed to various subfields including hematology, genetics, molecular biology, pathology and forensic medicine, and immunology.

Their work covers several main topics, reflecting a focus on blood-related diseases and disorders:

  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Immune Cell Function and Interaction

Giorgina Specchia has published in numerous scientific journals, with frequent appearances in the following venues:

  • Blood
  • Cancers
  • International Journal of Molecular Sciences
  • Annals of Hematology
  • Frontiers in Oncology

Among recent publications are papers such as:

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, 2020, The Lancet Haematology
  • A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia, 2020, Blood
  • Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study, 2020, Leukemia
  • Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies, 2020, International Journal of Molecular Sciences
  • New Insights into Diffuse Large B-Cell Lymphoma Pathobiology, 2020, Cancers

Specchia collaborates regularly with a number of co-authors across different projects. Frequent co-authors include Pellegrino Musto, Francesco Albano, Luisa Anelli, Antonella Zagaria, and Cosimo Cumbo.

Best Publications

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

    Giampaolo Bucaneve;Alessandra Micozzi;Francesco Menichetti;Pietro Martino

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature

    Corrado Girmenia;Livio Pagano;Bruno Martino;Domenico D'Antonio

  • ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

    Simonetta Viviani;Pier Luigi Zinzani;Alessandro Rambaldi;Ercole Brusamolino

  • Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

    Luciana Annino;Maria Luce Vegna;Andrea Camera;Giorgina Specchia

  • Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Francesco Lo-Coco;Giuseppe Avvisati;Marco Vignetti;Massimo Breccia

  • Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

    Livio Pagano;Morena Caira;Anna Candoni;Massimo Offidani

  • Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

    Paolo Gorello;G. Cazzaniga;F. Alberti;M. G. Dell'Oro

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    Michele Cavo;Meral Beksac;Lucia Pantani

  • Itraconazole Oral Solution as Prophylaxis for Fungal Infections in Neutropenic Patients with Hematologic Malignancies: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial

    Menichetti F;Del Favero A;Martino P;Bucaneve G

  • Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Pancrazzi

  • Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

    Vera Grossmann;Enrico Tiacci;Antony B. Holmes;Alexander Kohlmann

  • JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

    Giovanni Barosi;Gaetano Bergamaschi;Monia Marchetti;Alessandro M. Vannucchi

  • Therapy of molecular relapse in acute promyelocytic leukemia.

    Francesco Lo Coco;Daniela Diverio;Giuseppe Avvisati;Maria C. Petti

  • Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.

    Paola Guglielmelli;Giovanni Barosi;Giorgina Specchia;Alessandro Rambaldi

  • Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.

    Michele Baccarani;Gianantonio Rosti;Fausto Castagnetti;Ibrahim Haznedaroglu

  • A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.

    Marco Mancini;Daniela Scappaticci;Giuseppe Cimino;Mauro Nanni

  • AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

    Giuseppe Avvisati;Francesco Lo-Coco;Francesca Paola Paoloni;Maria Concetta Petti

Frequent Co-Authors

Giovanni Martinelli
Giovanni Martinelli University of Bologna
Michele Baccarani
Michele Baccarani University of Bologna
Giuseppe Saglio
Giuseppe Saglio University of Turin
Francesco Di Raimondo
Francesco Di Raimondo University of Catania
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
Franco Mandelli
Franco Mandelli Sapienza University of Rome
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Mariano Rocchi
Mariano Rocchi University of Bari Aldo Moro
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Livio Pagano
Livio Pagano Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean pursuing a traditional M.D. degree. There are many related online degrees that open doors to rewarding careers in healthcare. Programs such as a him associate degree online provide training in managing healthcare data and information systems, which are central to smooth healthcare operations.

For those interested in administrative roles, enrolling in the cheapest medical billing and coding online courses is a practical option. These programs prepare students to handle medical records and insurance claims, which are vital functions in any healthcare facility.

If you are more patient-facing, becoming a nurse practitioner is a popular path. You can now find cheapest online acute care nurse practitioner programs that are both flexible and affordable. Similarly, those starting their nursing journey can explore a variety of affordable nursing programs online, making it easier to enter the workforce while balancing other commitments.

These pathways offer accessible and cost-effective routes to build a successful healthcare career beyond traditional medical school.

Best Scientists Citing Giorgina Specchia

Trending Scientists

Recently Published Articles